Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab

Table 1

Distribution of patients into groups A and B and subgroups 1, 2, 3, and 4.

		Group A	Group B
1	Pterygium	6	12
2	NV after penetrating keratoplasty	8	6
3	Alkali burn	3	1
	Vascularized scar after corneal ulcer	3	2
	NV after herpetic keratitis	1	2
	Stevens-Johnson syndrome	2	1
	Other etiology	4	9
4	Preparation for penetrating keratoplasty	1	5